The pharmaceutical industry heavily relies on external sources to supplement its internal R&D activities and fill its product pipelines. Outsourcing of workpackages, in-licensing of development projects, collaborations with academic research centers or biotech companies and hiring of consultants are classic approaches towards this goal. Here we describe a new open innovation approach, termed �…